GlaxoSmithKline Plc has agreed to buy U.S. consumer healthcare firm CNS Inc. for $566 million in cash, Europe’s biggest drug maker said on Monday.
*For more on this story,
read the full Reuters article.
GlaxoSmithKline Plc has agreed to buy U.S. consumer healthcare firm CNS Inc. for $566 million in cash, Europe’s biggest drug maker said on Monday.
*For more on this story,
read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99